Related Experiment Video

Updated: Apr 23, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Biomarkers for MS: unpuzzling the progressive multiple sclerosis puzzle

Robert J Fox1

  • 1From the Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, OH. foxr@ccf.org.

Neurology
|September 26, 2014
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

10.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

Related Experiment Videos

Last Updated: Apr 23, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

10.6K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

9
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
9

Articles linked to this work by shared authors, journal, and citation graph.

Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years.

Multiple sclerosis and related disorders·2026

Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases.

Multiple sclerosis journal - experimental, translational and clinical·2026

Vidofludimus calcium for the treatment of multiple sclerosis: development rationale, mechanism of action, and early trial data.

Expert opinion on investigational drugs·2026

Men's health research priorities in men with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2026

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.

Drugs·2026

Use of semaglutide and tirzepatide among people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Clinical Reasoning: A 79-Year-Old Man With Subacute Onset Involuntary Facial Movements and Discoordination.

Neurology·2026

Machine Learning Characterization of Readmissions After Chronic Subdural Hematoma Hospitalizations.

Neurology·2026

Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology·2026

Pearls & Oy-sters: Bilateral Neuropathic Facial Pain With Autonomic Features and Neurovascular Contact.

Neurology·2026

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Neurology·2026

Glucose and Methionine Metabolism in Disorders of Consciousness After Brain Injury: An Exploratory Longitudinal PET Study.

Neurology·2026

When a Mimicker Is Mimicked: A Case report on Acid-Fast Atypical Lepromatous Leprosy Mimicking Tuberculosis.

Indian journal of medical microbiology·2026

Proposed Solutions for a Multiple Myeloma Case with Unobtainable Serum.

Clinical laboratory·2026

Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Mosaic Loss of Y Chromosome and Risks of Peripheral Arterial and Aortic Diseases.

JACC. Advances·2026

Overlapping mycoses in a case of Seborrheic dermatitis with coexistent Malassezia folliculitis.

Medical mycology case reports·2026

Correction: MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us